Seymour H. Fein

Seymour H. Fein

Chief Tech/Sci/R&D Officer at ONCOTELIC THERAPEUTICS, INC.

75 year
Health Technology
Consumer Services
Finance

Profile

Seymour H.
Fein
is the founder of Serenity Pharmaceuticals Corp.
(founded in 2007) where he holds the title of Chief Medical Officer & Principal.
He is currently the Chief Medical & Regulatory Officer at Oncotelic Therapeutics, Inc. (since 2022) and the Chief Medical Officer at Ventria Bioscience, Inc. (since 2015).
In his former positions, he served as a Medical Director at Bayer Pharmaceuticals Corp., Bayer HealthCare Pharmaceuticals, Inc., Ohmeda PPD, Inc., Rorer Group, Inc., and Ohmeda, Inc. He was also a Director-Clinical Research & Development at Ohmeda PPD, Inc. Additionally, he held the position of Independent Director at Prospect Park Capital Corp.
from 2016 to 2020.
Dr. Fein was the Chief Medical Officer at Oncotelic Therapeutics, Inc. and Delcath Systems, Inc. from 2006 to 2008.
He also worked as a Senior Research Physician at Hoffmann-La Roche, Inc. and as a Principal at the US Food & Drug Administration.
Dr. Fein obtained his undergraduate degree from the University of Pennsylvania and his doctorate from New York Medical College.

Seymour H. Fein active positions

CompaniesPositionStart
ONCOTELIC THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 28/02/2023
Chief Tech/Sci/R&D Officer 11/05/2015
Founder 01/01/2007
All active positions of Seymour H. Fein

Former positions of Seymour H. Fein

CompaniesPositionEnd
PROSPECT PARK CAPITAL CORP. Director/Board Member 23/01/2020
DELCATH SYSTEMS, INC. Chief Tech/Sci/R&D Officer 17/07/2008
ONCOTELIC THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer -
ADHERA THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer -
Bayer Pharmaceuticals Corp. Chief Tech/Sci/R&D Officer -
See the detail of Seymour H. Fein's experience

Training of Seymour H. Fein

University of Pennsylvania Undergraduate Degree
New York Medical College Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Seymour H. Fein's experience

Connections

40

1st degree connections

15

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies4
ONCOTELIC THERAPEUTICS, INC.

Health Technology

DELCATH SYSTEMS, INC.

Health Technology

PROSPECT PARK CAPITAL CORP.

Finance

ADHERA THERAPEUTICS, INC.

Health Technology

Private companies9
Bayer Pharmaceuticals Corp.

Health Technology

Government

Health Technology

Health Technology

Ohmeda PPD, Inc.

Health Technology

Health Technology

Ohmeda, Inc.

See company connections
  1. Stock Market
  2. Insiders
  3. Seymour H. Fein